Supernus Pharmaceuticals Income Taxes 2011-2024 | SUPN

Supernus Pharmaceuticals income taxes from 2011 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Supernus Pharmaceuticals Annual Income Taxes
(Millions of US $)
2023 $1
2022 $0
2021 $20
2020 $42
2019 $34
2018 $29
2017 $43
2016 $-41
2015 $1
2014 $1
2013 $0
2012 $
2011 $-16
2010 $-0
Supernus Pharmaceuticals Quarterly Income Taxes
(Millions of US $)
2024-06-30 $6
2024-03-31 $0
2023-12-31 $-0
2023-09-30 $26
2023-06-30 $-16
2023-03-31 $-8
2022-12-31 $10
2022-09-30 $-2
2022-06-30 $3
2022-03-31 $-11
2021-12-31 $-0
2021-09-30 $7
2021-06-30 $8
2021-03-31 $5
2020-12-31 $9
2020-09-30 $13
2020-06-30 $13
2020-03-31 $8
2019-12-31 $8
2019-09-30 $11
2019-06-30 $10
2019-03-31 $6
2018-12-31 $13
2018-09-30 $8
2018-06-30 $3
2018-03-31 $5
2017-12-31 $21
2017-09-30 $7
2017-06-30 $9
2017-03-31 $6
2016-12-31 $1
2016-09-30 $-43
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30 $0
2015-06-30 $0
2015-03-31 $0
2014-12-31
2014-09-30 $0
2014-06-30
2014-03-31 $0
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31 $-16
2011-09-30
2011-06-30
2011-03-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.771B $0.608B
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.120B 6.83
Dr Reddy's Laboratories (RDY) India $13.079B 19.59
BridgeBio Pharma (BBIO) United States $5.045B 0.00
Bausch Health Cos (BHC) Canada $2.956B 2.23
Amphastar Pharmaceuticals (AMPH) United States $2.438B 13.65
Taysha Gene Therapies (TSHA) United States $0.449B 73.00
Personalis (PSNL) United States $0.315B 0.00
Assembly Biosciences (ASMB) United States $0.117B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00